Protonix Delayed-release | Pantoprazole Sodium Granule, Delayed Release while Breastfeeding
American Academy of Pediatrics and other medical experts exclusively recommend to breastfeed the baby for first 6 months. Once you introduce baby to other foods it is recommended to breastfeed for at least first year of babys life. Taking medication while breastfeeding could be tricky as most drugs pass in breast milk. In this article we will evaluate Protonix Delayed-release | Pantoprazole Sodium Granule, Delayed Release for its safety in breastfeeding.

What is Protonix Delayed-release | Pantoprazole Sodium Granule, Delayed Release ?


PROTONIX For Delayed-Release Oral Suspension and PROTONIX Delayed-Release Tablets are indicated for: PROTONIX is a proton pump inhibitor indicated for the following: •Short-Term Treatment of Erosive Esophagitis Associated with Gastroesophageal Reflux Disease (GERD) (1.1) •Maintenance of Healing of Erosive Esophagitis (1.2) •Pathological Hypersecretory Conditions Including Zollinger-Ellison Syndrome (1.3) 1.1 Short-Term Treatment of Erosive Esophagitis Associated With Gastroesophageal Reflux Disease (GERD) PROTONIX is indicated in adults and pediatric patients five years of age and older for the short-term treatment (up to 8 weeks) in the healing and symptomatic relief of erosive esophagitis. For those adult patients who have not healed after 8 weeks of treatment, an additional 8-week course of PROTONIX may be considered. Safety of treatment beyond 8 weeks in pediatric patients has not been established. 1.2 Maintenance of Healing of Erosive Esophagitis PROTONIX is indicated for maintenance of healing of erosive esophagitis and reduction in relapse rates of daytime and nighttime heartburn symptoms in adult patients with GERD. Controlled studies did not extend beyond 12 months. 1.3 Pathological Hypersecretory Conditions Including Zollinger-Ellison Syndrome PROTONIX is indicated for the long-term treatment of pathological hypersecretory conditions, including Zollinger-Ellison syndrome.

Is using Protonix Delayed-release | Pantoprazole Sodium Granule, Delayed Release safe or dangerous while breastfeeding?

Protonix Delayed-release | Pantoprazole Sodium Granule, Delayed Release safe for breastfeeding
Active ingredient in Protonix Delayed-release | Pantoprazole Sodium Granule, Delayed Release is Pantoprazole and based on our analysis of Pantoprazole it appears that using Protonix Delayed-release | Pantoprazole Sodium Granule, Delayed Release is safe in breastfeeding. Below is analysis of Pantoprazole while breastfeeding.

Statement of Manufacturer/Labeler about breastfeeding usage
8.3 Nursing Mothers Pantoprazole and its metabolites are excreted in the milk of rats. Pantoprazole excretion in human milk has been detected in a study of a single nursing mother after a single 40 mg oral dose. The clinical relevance of this finding is not known. Many drugs which are excreted in human milk have a potential for serious adverse reactions in nursing infants. Based on the potential for tumorigenicity shown for pantoprazole in rodent carcinogenicity studies, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the benefit of the drug to the mother.

Protonix Delayed-release | Pantoprazole Sodium Granule, Delayed Release Breastfeeding Analsys


Pantoprazole while Breastfeeding

Safe

CAS Number: 102625-70-7

Due to a high serum-protein-binding capacity, excretion into breast milk is non-significant without side-effects among breastfed infants from treated mothers. Since it's neutralized by the acid pH of stomach, capsules with enteric coated granules are used. Because of this, it is thought that the small quantity of Pantoprazole that may reach the breast milk would be neutralized by infant's stomach. In addition, absorption is greatly decreased by the presence of food. No effect on Prolactin secretion has been observed. Other formulations of Pantoprazole without anti-acid protection are destroyed in the stomach.


Protonix Delayed-release | Pantoprazole Sodium Granule, Delayed Release Breastfeeding Analsys - 2


Pantoprazole while Breastfeeding

CAS Number: 102625-70-7

Maternal pantoprazole doses of 40 mg daily produce low levels in milk and would not be expected to cause any adverse effects in breastfed infants.


Protonix Delayed-release | Pantoprazole Sodium Granule, Delayed Release and breastfeeding

I already used Protonix Delayed-release | Pantoprazole Sodium Granule, Delayed Release and meanwhile I breastfed my baby should I be concerned?

It is always a good idea to keep your healthcare provider or doctor informed about your drug usage during pregnancy and breastfeeding but if you have not informed your doctor about Protonix Delayed-release | Pantoprazole Sodium Granule, Delayed Release and have used it then do not panic as Protonix Delayed-release | Pantoprazole Sodium Granule, Delayed Release is mostly safe in breastfeeding and should not cause any harm to your baby.


My doctor has prescribed me Protonix Delayed-release | Pantoprazole Sodium Granule, Delayed Release, what should I do?

Definitely, Protonix Delayed-release | Pantoprazole Sodium Granule, Delayed Release is safe in lactation for baby. No wonder your doctor has recommended it.


If I am using Protonix Delayed-release | Pantoprazole Sodium Granule, Delayed Release, will my baby need extra monitoring?

No extra baby monitoring required while mother is using Protonix Delayed-release | Pantoprazole Sodium Granule, Delayed Release


Who can I talk to if I have questions about usage of Protonix Delayed-release | Pantoprazole Sodium Granule, Delayed Release in breastfeeding?

US
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday

UK
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700

Australia
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week

Canada
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week